TY  - GEN
AU  - Tsuchiya,Tomoshi
AU  - Nagayasu,Takeshi
AU  - Yamasaki,Naoya
AU  - Matsumoto,Keitaro
AU  - Miyazaki,Takuro
AU  - Tagawa,Tsutomu
AU  - Nakamura,Akihiro
AU  - Minami,Hiroyuki
AU  - Taniguchi,Hideki
AU  - Akamine,Shinji
AU  - Hisano,Hiroshi
AU  - Taniguchi,Yoshitaka
TI  - A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates
SN  - 1938-0690
PY  - 2013///0308
KW  - Administration, Oral
KW  - Aged
KW  - Ambulatory Care
KW  - methods
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Combinations
KW  - Feasibility Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Incidence
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Oxonic Acid
KW  - Tegafur
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.cllc.2012.01.005
ER  -